CD274 and neoplasm: As PD-L1 binds to programmed death protein 1 (PD-1) receptor on T cells, the PD-1/PD-L1 pathway can inhibit both innate and adaptive immune cell functions, triggering the tumour-mediated immune suppression in the TME [30].